We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Could a Breathalyzer Detect Cancer?

Video

Discover how scientists are analyzing compounds in the breath to create a versatile breathalyzer capable of detecting disease.

Watch Now

Personalized Medicine and Cancer

Infographic

The aim of personalized medicine is to a move away from the traditional “one size fits all” approach to the treatment of diseases – such as cancer. For patients where standard clinical options have been exhausted, novel personalized therapeutics may be required. Patient-derived cancer models, such as “organoids”, can help predict an individual’s response to a drug – both efficacy and toxicity – prior to administration.

Read more

Top 10 Cancer Research News Stories of 2019

List

2019 has been an exciting year for the cancer research field. This list details the top 10 most-read news stories from the field this year, published on Technology Networks.

Read more

Predicting Melanoma Patients at Risk of Cancer Recurrence

News

Technique reveals that primary melanoma patients with lower T-cell fraction are 2.5 times more likely to have cancer metastasize than patients with higher T-cell fraction.

Read more
 
Common Drug Counteracts Treatment Resistance in Patients With Leukemia
News

A new study suggests that a common and inexpensive drug may be used to counteract treatment resistance in patients with acute myeloid leukemia (AML).

Read more

Magnetized Molecules Help Monitor Breast Cancer
News

A new type of scan has been developed that involves magnetizing molecules – it allows physicians to observe in real-time which regions of a breast tumor are active.

Read more

Studies Point to Important Role for B Cells in Promoting Anti-tumor Immunity
News

The likelihood of a patient responding to immune checkpoint blockade may depend on B cells in the tumor, located within specialized immune-cell clusters known as tertiary lymphoid structures (TLS), according to researchers at The University of Texas MD Anderson Cancer Center.

Read more

 
 
 
 
Missense, Nonsense and Frameshift Mutations: A Genetic Guide
Article

If you want to build a foundational understanding of genomics in both health and disease, it's important to be able to distinguish between the different type of genetic mutations that can occur. Here, we take a look at some of the mutations that can be encountered and the impact they have on the genome.

Read more

Exploring the Medicinal Benefits of Cannabis Within UK Pharmaceuticals
Article

In this article, we explore how the use of cannabis within UK pharmaceuticals is expected to change, as well as the medicinal benefits offered by cannabis, and cannabinoids.

Read more

The Importance of Understanding Target–Protein Interactions in Drug Discovery
Article

You’re unwell, you see a doctor, they prescribe you a medicine… and you take it. But how exactly is that drug having an effect? What is its mechanism of action? Drugs exhibit their effects through specific protein–target interactions. Andrew Lynn, Chief Executive Officer at Fluidic Analytics discusses why understanding protein–target interactions is so important.

Read more

Liquid Biopsy: Guide, Applications and Techniques
Article

Liquid biopsies are tests conducted on blood samples that examine biomarkers shed by tumors, such as cancer cells or pieces of tumor DNA. The data from liquid biopsies can be used in place of or alongside that of traditional surgical biopsies. In this article, we review the theory behind liquid biopsies and their applications in cancer medicine.

Read more

The Pursuit of Spotting and Steering Cell Death
Article

Here, we examine one common branch of cell death, apoptosis, and explain why studying aberrations in apoptotic signaling is important for understanding and addressing a range of human pathologies. We also highlight techniques that enable studies of apoptosis.

Read more

Future Cancer Immunotherapy Treatments Could Be Administered by a Pill
Article

Immunotherapies delivered in pill form aren’t yet the default cancer treatment. Techniques like protein painting are bringing that day closer.

Read more